Laboratoires Théa

Laboratoires Théa company information, Employees & Contact Information

Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries.

Company Details

Employees
881
Address
12 Rue Louis Bleriot, Clermont-Ferrand,auvergne-Rhone-Alpes 63100,france
Phone
33 4 73 98 14 36
Email
gl****@****thea.fr
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Clermont-Ferrand, Auvergne-Rhone-Alpes
Looking for a particular Laboratoires Théa employee's phone or email?

Laboratoires Théa Questions

News

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada - LENZ Therapeutics

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada LENZ Therapeutics

LENZ Therapeutics and Laboratoires Théa partner to commercialize LNZ100 for presbyopia in Canada - Ophthalmology Times

LENZ Therapeutics and Laboratoires Théa partner to commercialize LNZ100 for presbyopia in Canada Ophthalmology Times

Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye - Business Wire

Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye Business Wire

Thea Pharma Inc. Launches Preservative Freedom Coalition to Advocate for Preservative-free Eye Care - PR Newswire

Thea Pharma Inc. Launches Preservative Freedom Coalition to Advocate for Preservative-free Eye Care PR Newswire

Laboratoires Thea - The Pharma Letter

Laboratoires Thea The Pharma Letter

Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy - Pharmaceutical Technology

Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy Pharmaceutical Technology

Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront, up to $285 Million in Clini - Yahoo Finance

Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront, up to $285 Million in Clini Yahoo Finance

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada - VisionMonday.com

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada VisionMonday.com

ProQR, Théa ink new $8.6M pact for eye assets after old one collapsed - Fierce Biotech

ProQR, Théa ink new $8.6M pact for eye assets after old one collapsed Fierce Biotech

Novaliq and Laboratoires Théa get EC nod for Vevizye eye drop solution - World Pharmaceutical Frontiers

Novaliq and Laboratoires Théa get EC nod for Vevizye eye drop solution World Pharmaceutical Frontiers

THĒA, EUROPE'S LEADER IN PRESERVATIVE-FREE EYE CARE, LAUNCHES CANADIAN AFFILIATE - PR Newswire Canada

THĒA, EUROPE'S LEADER IN PRESERVATIVE-FREE EYE CARE, LAUNCHES CANADIAN AFFILIATE PR Newswire Canada

Thea Pharma Announces FDA Approval of IYUZEH™ for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-angle Glaucoma or Ocular Hypertension - Business Wire

Thea Pharma Announces FDA Approval of IYUZEH™ for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-angle Glaucoma or Ocular Hypertension Business Wire

Explore the safety, usability of multidose preservative-free tears - Healio

Explore the safety, usability of multidose preservative-free tears Healio

Novaliq and Laboratoires Théa announce European Commission approval of ciclosporin 0.1% eye drops solution - Ophthalmology Times Europe

Novaliq and Laboratoires Théa announce European Commission approval of ciclosporin 0.1% eye drops solution Ophthalmology Times Europe

Thea Pharma Inc. Launches IYUZEH™ (latanoprost ophthalmic solution) 0.005% in the U.S. - PR Newswire

Thea Pharma Inc. Launches IYUZEH™ (latanoprost ophthalmic solution) 0.005% in the U.S. PR Newswire

Théa Completes its Acquisition of Akorn’s Branded Ophthalmic Products Expanding its Presence in the United States Eye Care Industry - Business Wire

Théa Completes its Acquisition of Akorn’s Branded Ophthalmic Products Expanding its Presence in the United States Eye Care Industry Business Wire

Labtician Ophthalmics and Laboratoires Théa Announce Joint Venture - PR Newswire Canada

Labtician Ophthalmics and Laboratoires Théa Announce Joint Venture PR Newswire Canada

Laboratoires Théa acquires The EyeBag brand - Association of Optometrists (AOP)

Laboratoires Théa acquires The EyeBag brand Association of Optometrists (AOP)

Top Laboratoires Théa Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant